Acrospire Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-917
Closed -$5K 160
2017
Q2
$5K Buy
+917
New +$5K ﹤0.01% 1953